Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchodilator pharmacodynamics

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 5, 1999, Pages 519-525

  Lima, John J ^b   Thomason, Donald B ^c   Mohamed, Mohamad H N ^c   Eberle, Louis V ^c   Self, Timothy H ^c   Johnson, Julie A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NEMOURS CHILDREN S CLINIC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ARGININE; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; GLYCINE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; SEVERITY OF ILLNESS INDEX;

EID: 0345501553     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70071-8     Document Type: Article

References (22)

1. 1. Morgan DJ. Clinical pharmacokinetics of beta-agonists. Clin Pharmacokinet 1990;18:270-94.
2. 2. Lohse MJ. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993;1179:171-88.
3. 3. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-9.
4. 4. Turki J, Pak J, Green SA, Martin RJ, Liggett SB. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995;95:1635-41.
5. 5. Hall IP, Wheatley A, Wilding P, Liggett SB. Association of Glu27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995;345: 1213-4.
6. 6. Tan S, Hall IP, Dewar J, Dow E, Lipworth B. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics [see comments]. Lancet 1997;350:995-9.
7. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol 1997;100:261-5.
8. 2-adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;156: S156-62.
9. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-8.
10. 2-adrenoceptor function. J Clin Invest 1997;100:3005-13.
11. 2-adrenoceptor with reported childhood asthma: population based study. BMJ 1998;316:664.
12. 2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma. Eur Respir J 1998;11:589-593.
13. 2-Adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. J Allergy Clin Immunol 1998;101:337-41.
14. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties [published erratum appears in Biochemistry 1994;33: 14368]. Biochemistry 1994;33:9414-9.
15. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995;13:25-33.
16. 16. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; 1991. Publication no 91-3042.
17. 17. Mohamad M, Lima JJ, Eberle LV, Self TH, Johnson JA. Effects of gender and race on albuterol pharmacokinetics. Pharmacotherapy 1999;19:157-61.
18. 18. Gupta RN, Fuller HD, Dolovich MB. Optimization of a column liquid chromatographic procedure for the determination of plasma salbutamol concentration. J Chromatogr B Biomed Appl 1994;654:205-11.
19. 19. Standardization of spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152: 1107-36.
20. 20. Knudson RJ, Schroter RC, Knudson DE, Sugihara S. Influence of airway geometry on expiratory flow limitation and density dependence. Respir Physiol 1983;52: 113-23.
21. 21. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs (NJ): Prentice Hall; 1984.
22. 22. Scars MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, et al. Regular inhaled β-agonist treatment in bronchial asthma [see comments]. Lancet 1990;336:1391-6.